Bruno Porto Pessoa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bruno Porto Pessoa has a total of 208 co-authors. Here are the top co-authors by number of shared publications:
- Milena Soriano Marcolino
Medical School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
5 shared publications - Christiane Corrêa Rodrigues Cimini
Hospital Santa Rosalia, Teófilo Otoni, Brazil
4 shared publications - Fernando Anschau
Grupo Hospitalar Conceição Porto Alegre Brazil
4 shared publications - Magda Carvalho Pires
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
4 shared publications - Marcelo Carneiro
Universidade de Santa Cruz do Sul
4 shared publications - Polianna Delfino-Pereira
Department of Internal Medicine, Medical School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
4 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e86379
Beyond Area Under the Receiver Operating Characteristic Curve: Evaluating Predictive Performance Metrics Under Class Imbalance in Real-World Clinical Data
Background: Predictive models increasingly support clinical decision-making, although imbalanced outcome distributions are common in health care datasets and can distort performance evaluation. The area under the receiver operating characteristic curve (AUROC) remains the most frequently reported metric, despite its limited ability to reflect clinically meaningful performance under class imbalance. Objective: This study aimed to examine the influences of metric selection on the clinical interpretation of predictive models in imbalanced real-world health care data. Methods: This was a retrospective cohort study, including 17,018 hospitalized patients with COVID-19. Two predictive models using extreme gradient boosting (XGBoost) were developed to predict kidney replacement therapy (KRT) and mortality. Model performance was assessed using AUROC, macro- F 1 -score, class-specific precision and recall, calibration (curve, slope, and intercept), decision curve analysis, and learning curves. Standard rebalancing strategies were applied exclusively to the training data to evaluate their impact on performance. Results: KRT occurred in 9.5%, and mortality in 18.0%. Although AUROC values were high (0.928 for KRT and 0.945 for mortality), performance in the minority class was substantially lower. For KRT, precision was 0.539 and recall 0.372; for mortality, precision was 0.725 and recall 0.718. Rebalancing strategies were associated with higher recall for the minority class, but this gain was accompanied by a reduction in precision, with minimal impact on AUROC values. As a result, AUROC remained high despite clinically relevant changes in error distribution between false positives and false negatives. The learning curves show a plateau-like shape, with stable validation performance across all training set sizes for both outcomes. Conclusions: AUROC alone is insufficient to evaluate prediction models in imbalanced health care scenarios, even with rebalancing. Routine reporting of class-aware metrics, alongside learning curve analysis, is essential to support robust and clinically meaningful evaluation of predictive models, rather than their direct translation into practice.
- 24 June 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e86379
Open AccessBeyond Area Under the Receiver Operating Characteristic Curve: Evaluating Predictive Performance Metrics Under Class Imbalance in Real-World Clinical Data
Background: Predictive models increasingly support clinical decision-making, although imbalanced outcome distributions are common in health care datasets and can distort performance evaluation. The area under the receiver operating characteristic curve (AUROC) remains the most frequently reported metric, despite its limited ability to reflect clinically meaningful performance under class imbalance. Objective: This study aimed to examine the influences of metric selection on the clinical interpretation of predictive models in imbalanced real-world health care data. Methods: This was a retrospective cohort study, including 17,018 hospitalized patients with COVID-19. Two predictive models using extreme gradient boosting (XGBoost) were developed to predict kidney replacement therapy (KRT) and mortality. Model performance was assessed using AUROC, macro- F 1 -score, class-specific precision and recall, calibration (curve, slope, and intercept), decision curve analysis, and learning curves. Standard rebalancing strategies were applied exclusively to the training data to evaluate their impact on performance. Results: KRT occurred in 9.5%, and mortality in 18.0%. Although AUROC values were high (0.928 for KRT and 0.945 for mortality), performance in the minority class was substantially lower. For KRT, precision was 0.539 and recall 0.372; for mortality, precision was 0.725 and recall 0.718. Rebalancing strategies were associated with higher recall for the minority class, but this gain was accompanied by a reduction in precision, with minimal impact on AUROC values. As a result, AUROC remained high despite clinically relevant changes in error distribution between false positives and false negatives. The learning curves show a plateau-like shape, with stable validation performance across all training set sizes for both outcomes. Conclusions: AUROC alone is insufficient to evaluate prediction models in imbalanced health care scenarios, even with rebalancing. Routine reporting of class-aware metrics, alongside learning curve analysis, is essential to support robust and clinically meaningful evaluation of predictive models, rather than their direct translation into practice.
- Open Access
- 24 February 2025
- Published by Instituto Adolfo Lutz in Revista Do Instituto Adolfo Lutz
- Vol. 84, 1-8
Perfil epidemiológico dos pacientes atendidos em 2020 e 2021 com diagnóstico de COVID-19 em hospital particular de Belo Horizonte
O objetivo foi descrever o perfil epidemiológico dos pacientes internados no Hospital Felício Rocho de Belo Horizonte, MG, com o diagnóstico positivo para a COVID-19 em categorias de sexo, idade, sintomas, passagem pelo CTI, necessidade de ventilação mecânica e desfecho. Trata-se de estudo retrospectivo epidemiológico conduzido em um hospital privado de grande porte em Belo Horizonte, com 3.034 pacientes diagnosticados com COVID-19 entre março de 2020 e dezembro de 2021. Variáveis consideradas: gênero, idade, sintomas, necessidade de terapia intensiva, ventilação mecânica e mortalidade. A análise descritiva utilizou a mediana para dados numéricos e frequências absolutas e relativas para variáveis categóricas. Os sintomas mais comuns em pacientes hospitalizados com COVID-19 incluem tosse, mialgia, cefaleia, febre, coriza, odinofagia, dispneia e diarreia. A tosse foi o sintoma mais prevalente entre os pacientes, enquanto outros estudos relataram febre, dispneia e taquicardia como os sintomas mais comuns. A necessidade de internação no CTI e uso de ventilação mecânica foram menores no hospital estudado em relação a outros estudos, assim como a média de idade dos pacientes. As limitações incluem a falta de informações sobre comorbidades e a contabilização de óbitos apenas após a passagem pelo CTI.
- 24 February 2025
- Published by Instituto Adolfo Lutz in Revista Do Instituto Adolfo Lutz
- Vol. 84, 1-8
Open AccessPerfil epidemiológico dos pacientes atendidos em 2020 e 2021 com diagnóstico de COVID-19 em hospital particular de Belo Horizonte
O objetivo foi descrever o perfil epidemiológico dos pacientes internados no Hospital Felício Rocho de Belo Horizonte, MG, com o diagnóstico positivo para a COVID-19 em categorias de sexo, idade, sintomas, passagem pelo CTI, necessidade de ventilação mecânica e desfecho. Trata-se de estudo retrospectivo epidemiológico conduzido em um hospital privado de grande porte em Belo Horizonte, com 3.034 pacientes diagnosticados com COVID-19 entre março de 2020 e dezembro de 2021. Variáveis consideradas: gênero, idade, sintomas, necessidade de terapia intensiva, ventilação mecânica e mortalidade. A análise descritiva utilizou a mediana para dados numéricos e frequências absolutas e relativas para variáveis categóricas. Os sintomas mais comuns em pacientes hospitalizados com COVID-19 incluem tosse, mialgia, cefaleia, febre, coriza, odinofagia, dispneia e diarreia. A tosse foi o sintoma mais prevalente entre os pacientes, enquanto outros estudos relataram febre, dispneia e taquicardia como os sintomas mais comuns. A necessidade de internação no CTI e uso de ventilação mecânica foram menores no hospital estudado em relação a outros estudos, assim como a média de idade dos pacientes. As limitações incluem a falta de informações sobre comorbidades e a contabilização de óbitos apenas após a passagem pelo CTI.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 30 (8)
Factors associated with poor sleep quality in older Brazilians: a cross-sectional analysis of ELSI-BRAZIL
The aim is to identify the prevalence and main factors associated with self-reported poor sleep quality in Brazilian adults aged 50 and older. A cross-sectional study with participants from the Brazilian Longitudinal Study of Aging (2019-2021). A total of 9,849 participants aged 50 and older with complete information for the variables of interest were included. Self-reported sleep quality was the outcome variable. Independent variables included sociodemographic, behavioral, and health-related indicators. Poisson regression was performed to estimate prevalence ratios (PR) and their respective 95% confidence intervals (CI95%). The prevalence of poor sleep quality was 15.6%. Significant associations were observed between the outcome and male gender (PR = 0.70; CI95%: 0.61-0.81), self-rated good health (PR = 0.49; CI95%: 0.40-0.60), and residence in the southern region (PR = 0.68; CI95%: 0.49-0.94), the number of chronic diseases (PR = 2.52; CI95%: 1.97-3.24, for those with two or more), and self-rated poor memory (PR = 1.30; CI95%: 1.12-1.51). Poor sleep quality in Brazilian older adults was associated with various factors, including female gender, negative perception of health and memory, excessive alcohol consumption, and the presence of multiple chronic conditions.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 30 (8)
Open AccessFactors associated with poor sleep quality in older Brazilians: a cross-sectional analysis of ELSI-BRAZIL
The aim is to identify the prevalence and main factors associated with self-reported poor sleep quality in Brazilian adults aged 50 and older. A cross-sectional study with participants from the Brazilian Longitudinal Study of Aging (2019-2021). A total of 9,849 participants aged 50 and older with complete information for the variables of interest were included. Self-reported sleep quality was the outcome variable. Independent variables included sociodemographic, behavioral, and health-related indicators. Poisson regression was performed to estimate prevalence ratios (PR) and their respective 95% confidence intervals (CI95%). The prevalence of poor sleep quality was 15.6%. Significant associations were observed between the outcome and male gender (PR = 0.70; CI95%: 0.61-0.81), self-rated good health (PR = 0.49; CI95%: 0.40-0.60), and residence in the southern region (PR = 0.68; CI95%: 0.49-0.94), the number of chronic diseases (PR = 2.52; CI95%: 1.97-3.24, for those with two or more), and self-rated poor memory (PR = 1.30; CI95%: 1.12-1.51). Poor sleep quality in Brazilian older adults was associated with various factors, including female gender, negative perception of health and memory, excessive alcohol consumption, and the presence of multiple chronic conditions.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 30 (8) , e19642023
Fatores associados à má qualidade do sono em brasileiros mais velhos: uma análise transversal do ELSI-Brasil
Resumo O objetivo é identificar a prevalência e os fatores associados à má qualidade do sono autorreferida em adultos e idosos brasileiros com 50 anos ou mais. Trata-se de um estudo transversal com participantes do Estudo Longitudinal da Saúde dos Idosos Brasileiros (2019-2021). Foram incluídos 9.849 participantes com idade maior ou igual a 50 anos com informações completas para as variáveis de interesse. A qualidade do sono autorreferida foi a variável de desfecho. As variáveis independentes compreenderam indicadores sociodemográficos, comportamentais e condições de saúde. Foi feita a regressão de Poisson para estimativa das razões de prevalência (RP) e os respectivos intervalos de 95% de confiança (IC95%). A prevalência de má qualidade do sono foi de 15,6%. Foram observadas associações significativas entre o desfecho e sexo masculino (RP = 0,70; IC95%: 0,61- 0,81), avaliar a saúde como boa (RP = 0,49; IC95%: 0,40-0,60) e residir na região sul (RP = 0,68; IC95%: 0,49-0,94), número de doenças crônicas (2,52; IC95%: 1,97-3,24, para os com duas ou mais) e avaliar a memória como ruim (RP = 1,30; IC95%: 1,12-1,51). A má qualidade do sono em adultos mais velhos no Brasil foi associada com diversos fatores, incluindo sexo feminino, percepção negativa da saúde e da memória, consumo excessivo de álcool e a presença de múltiplas condições crônicas.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 30 (8) , e19642023
Open AccessFatores associados à má qualidade do sono em brasileiros mais velhos: uma análise transversal do ELSI-Brasil
Resumo O objetivo é identificar a prevalência e os fatores associados à má qualidade do sono autorreferida em adultos e idosos brasileiros com 50 anos ou mais. Trata-se de um estudo transversal com participantes do Estudo Longitudinal da Saúde dos Idosos Brasileiros (2019-2021). Foram incluídos 9.849 participantes com idade maior ou igual a 50 anos com informações completas para as variáveis de interesse. A qualidade do sono autorreferida foi a variável de desfecho. As variáveis independentes compreenderam indicadores sociodemográficos, comportamentais e condições de saúde. Foi feita a regressão de Poisson para estimativa das razões de prevalência (RP) e os respectivos intervalos de 95% de confiança (IC95%). A prevalência de má qualidade do sono foi de 15,6%. Foram observadas associações significativas entre o desfecho e sexo masculino (RP = 0,70; IC95%: 0,61- 0,81), avaliar a saúde como boa (RP = 0,49; IC95%: 0,40-0,60) e residir na região sul (RP = 0,68; IC95%: 0,49-0,94), número de doenças crônicas (2,52; IC95%: 1,97-3,24, para os com duas ou mais) e avaliar a memória como ruim (RP = 1,30; IC95%: 1,12-1,51). A má qualidade do sono em adultos mais velhos no Brasil foi associada com diversos fatores, incluindo sexo feminino, percepção negativa da saúde e da memória, consumo excessivo de álcool e a presença de múltiplas condições crônicas.
- 17 April 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 227, 107635
AB2CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units
- 17 April 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 227, 107635
AB2CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units
- Open Access
- 5 January 2024
- Published by Springer Nature in BMC Geriatrics
- Vol. 24 (1) , 1-11
Clinical characteristics and outcomes of COVID-19 patients with preexisting dementia: a large multicenter propensity-matched Brazilian cohort study
Background: Although dementia has emerged as an important risk factor for severe SARS-CoV-2 infection, results on COVID-19-related complications and mortality are not consistent. We examined the clinical presentations and outcomes of COVID-19 in a multicentre cohort of in-hospital patients, comparing those with and without dementia. Methods: This retrospective observational study comprises COVID-19 laboratory-confirmed patients aged ≥ 60 years admitted to 38 hospitals from 19 cities in Brazil. Data were obtained from electronic hospital records. A propensity score analysis was used to match patients with and without dementia (up to 3:1) according to age, sex, comorbidities, year, and hospital of admission. Our primary outcome was in-hospital mortality. We also assessed admission to the intensive care unit (ICU), invasive mechanical ventilation (IMV), kidney replacement therapy (KRT), sepsis, nosocomial infection, and thromboembolic events. Results: Among 1,556 patients included in the study, 405 (4.5%) had a diagnosis of dementia and 1,151 were matched controls. When compared to matched controls, patients with dementia had a lower frequency of dyspnoea, cough, myalgia, headache, ageusia, and anosmia; and higher frequency of fever and delirium. They also had a lower frequency of ICU admission (32.7% vs. 47.1%, p < 0.001) and shorter ICU length of stay (7 vs. 9 days, p < 0.026), and a lower frequency of sepsis (17% vs. 24%, p = 0.005), KRT (6.4% vs. 13%, p < 0.001), and IVM (4.6% vs. 9.8%, p = 0.002). There were no differences in hospital mortality between groups. Conclusion: Clinical manifestations of COVID-19 differ between older inpatients with and without dementia. We observed that dementia alone could not explain the higher short-term mortality following severe COVID-19. Therefore, clinicians should consider other risk factors such as acute morbidity severity and baseline frailty when evaluating the prognosis of older adults with dementia hospitalised with COVID-19.
- 5 January 2024
- Published by Springer Nature in BMC Geriatrics
- Vol. 24 (1) , 1-11
Open AccessClinical characteristics and outcomes of COVID-19 patients with preexisting dementia: a large multicenter propensity-matched Brazilian cohort study
Background: Although dementia has emerged as an important risk factor for severe SARS-CoV-2 infection, results on COVID-19-related complications and mortality are not consistent. We examined the clinical presentations and outcomes of COVID-19 in a multicentre cohort of in-hospital patients, comparing those with and without dementia. Methods: This retrospective observational study comprises COVID-19 laboratory-confirmed patients aged ≥ 60 years admitted to 38 hospitals from 19 cities in Brazil. Data were obtained from electronic hospital records. A propensity score analysis was used to match patients with and without dementia (up to 3:1) according to age, sex, comorbidities, year, and hospital of admission. Our primary outcome was in-hospital mortality. We also assessed admission to the intensive care unit (ICU), invasive mechanical ventilation (IMV), kidney replacement therapy (KRT), sepsis, nosocomial infection, and thromboembolic events. Results: Among 1,556 patients included in the study, 405 (4.5%) had a diagnosis of dementia and 1,151 were matched controls. When compared to matched controls, patients with dementia had a lower frequency of dyspnoea, cough, myalgia, headache, ageusia, and anosmia; and higher frequency of fever and delirium. They also had a lower frequency of ICU admission (32.7% vs. 47.1%, p < 0.001) and shorter ICU length of stay (7 vs. 9 days, p < 0.026), and a lower frequency of sepsis (17% vs. 24%, p = 0.005), KRT (6.4% vs. 13%, p < 0.001), and IVM (4.6% vs. 9.8%, p = 0.002). There were no differences in hospital mortality between groups. Conclusion: Clinical manifestations of COVID-19 differ between older inpatients with and without dementia. We observed that dementia alone could not explain the higher short-term mortality following severe COVID-19. Therefore, clinicians should consider other risk factors such as acute morbidity severity and baseline frailty when evaluating the prognosis of older adults with dementia hospitalised with COVID-19.
- Open Access
- 4 October 2023
- Published by Springer Nature in BMC Nephrology
- Vol. 24 (1) , 1-12
Temporal validation of the MMCD score to predict kidney replacement therapy and in-hospital mortality in COVID-19 patients
Background: Acute kidney injury has been described as a common complication in patients hospitalized with COVID-19, which may lead to the need for kidney replacement therapy (KRT) in its most severe forms. Our group developed and validated the MMCD score in Brazilian COVID-19 patients to predict KRT, which showed excellent performance using data from 2020. This study aimed to validate the MMCD score in a large cohort of patients hospitalized with COVID-19 in a different pandemic phase and assess its performance to predict in-hospital mortality. Methods: This study is part of the “Brazilian COVID-19 Registry”, a retrospective observational cohort of consecutive patients hospitalized for laboratory-confirmed COVID-19 in 25 Brazilian hospitals between March 2021 and August 2022. The primary outcome was KRT during hospitalization and the secondary was in-hospital mortality. We also searched literature for other prediction models for KRT, to assess the results in our database. Performance was assessed using area under the receiving operator characteristic curve (AUROC) and the Brier score. Results: A total of 9422 patients were included, 53.8% were men, with a median age of 59 (IQR 48–70) years old. The incidence of KRT was 8.8% and in-hospital mortality was 18.1%. The MMCD score had excellent discrimination and overall performance to predict KRT (AUROC: 0.916 [95% CI 0.909–0.924]; Brier score = 0.057). Despite the excellent discrimination and overall performance (AUROC: 0.922 [95% CI 0.914–0.929]; Brier score = 0.100), the calibration was not satisfactory concerning in-hospital mortality. A random forest model was applied in the database, with inferior performance to predict KRT requirement (AUROC: 0.71 [95% CI 0.69–0.73]). Conclusion: The MMCD score is not appropriate for in-hospital mortality but demonstrates an excellent predictive ability to predict KRT in COVID-19 patients. The instrument is low cost, objective, fast and accurate, and can contribute to supporting clinical decisions in the efficient allocation of assistance resources in patients with COVID-19.
- 4 October 2023
- Published by Springer Nature in BMC Nephrology
- Vol. 24 (1) , 1-12
Open AccessTemporal validation of the MMCD score to predict kidney replacement therapy and in-hospital mortality in COVID-19 patients
Background: Acute kidney injury has been described as a common complication in patients hospitalized with COVID-19, which may lead to the need for kidney replacement therapy (KRT) in its most severe forms. Our group developed and validated the MMCD score in Brazilian COVID-19 patients to predict KRT, which showed excellent performance using data from 2020. This study aimed to validate the MMCD score in a large cohort of patients hospitalized with COVID-19 in a different pandemic phase and assess its performance to predict in-hospital mortality. Methods: This study is part of the “Brazilian COVID-19 Registry”, a retrospective observational cohort of consecutive patients hospitalized for laboratory-confirmed COVID-19 in 25 Brazilian hospitals between March 2021 and August 2022. The primary outcome was KRT during hospitalization and the secondary was in-hospital mortality. We also searched literature for other prediction models for KRT, to assess the results in our database. Performance was assessed using area under the receiving operator characteristic curve (AUROC) and the Brier score. Results: A total of 9422 patients were included, 53.8% were men, with a median age of 59 (IQR 48–70) years old. The incidence of KRT was 8.8% and in-hospital mortality was 18.1%. The MMCD score had excellent discrimination and overall performance to predict KRT (AUROC: 0.916 [95% CI 0.909–0.924]; Brier score = 0.057). Despite the excellent discrimination and overall performance (AUROC: 0.922 [95% CI 0.914–0.929]; Brier score = 0.100), the calibration was not satisfactory concerning in-hospital mortality. A random forest model was applied in the database, with inferior performance to predict KRT requirement (AUROC: 0.71 [95% CI 0.69–0.73]). Conclusion: The MMCD score is not appropriate for in-hospital mortality but demonstrates an excellent predictive ability to predict KRT in COVID-19 patients. The instrument is low cost, objective, fast and accurate, and can contribute to supporting clinical decisions in the efficient allocation of assistance resources in patients with COVID-19.
- Open Access
- 21 August 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20220419
Factors associated with pulmonary infection in kidney and kidney-pancreas transplant recipients: a case-control study
Objective: To evaluate the etiology of and factors associated with pulmonary infection in kidney and kidney-pancreas transplant recipients. Methods: This was a single-center case-control study conducted between December of 2017 and March of 2020 at a referral center for kidney transplantation in the city of Belo Horizonte, Brazil. The case:control ratio was 1:1.8. Cases included kidney or kidney-pancreas transplant recipients hospitalized with pulmonary infection. Controls included kidney or kidney-pancreas transplant recipients without pulmonary infection and matched to cases for sex, age group, and donor type (living or deceased). Results: A total of 197 patients were included in the study. Of those, 70 were cases and 127 were controls. The mean age was 55 years (for cases) and 53 years (for controls), with a predominance of males. Corticosteroid use, bronchiectasis, and being overweight were associated with pulmonary infection risk in the multivariate logistic regression model. The most common etiologic agent of infection was cytomegalovirus (in 14.3% of the cases), followed by Mycobacterium tuberculosis (in 10%), Histoplasma capsulatum (in 7.1%), and Pseudomonas aeruginosa (in 7.1%). Conclusions: Corticosteroid use, bronchiectasis, and being overweight appear to be risk factors for pulmonary infection in kidney/kidney-pancreas transplant recipients, endemic mycoses being prevalent in this population. Appropriate planning and follow-up play an important role in identifying kidney and kidney-pancreas transplant recipients at risk of pulmonary infection.
- 21 August 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20220419
Open AccessFactors associated with pulmonary infection in kidney and kidney-pancreas transplant recipients: a case-control study
Objective: To evaluate the etiology of and factors associated with pulmonary infection in kidney and kidney-pancreas transplant recipients. Methods: This was a single-center case-control study conducted between December of 2017 and March of 2020 at a referral center for kidney transplantation in the city of Belo Horizonte, Brazil. The case:control ratio was 1:1.8. Cases included kidney or kidney-pancreas transplant recipients hospitalized with pulmonary infection. Controls included kidney or kidney-pancreas transplant recipients without pulmonary infection and matched to cases for sex, age group, and donor type (living or deceased). Results: A total of 197 patients were included in the study. Of those, 70 were cases and 127 were controls. The mean age was 55 years (for cases) and 53 years (for controls), with a predominance of males. Corticosteroid use, bronchiectasis, and being overweight were associated with pulmonary infection risk in the multivariate logistic regression model. The most common etiologic agent of infection was cytomegalovirus (in 14.3% of the cases), followed by Mycobacterium tuberculosis (in 10%), Histoplasma capsulatum (in 7.1%), and Pseudomonas aeruginosa (in 7.1%). Conclusions: Corticosteroid use, bronchiectasis, and being overweight appear to be risk factors for pulmonary infection in kidney/kidney-pancreas transplant recipients, endemic mycoses being prevalent in this population. Appropriate planning and follow-up play an important role in identifying kidney and kidney-pancreas transplant recipients at risk of pulmonary infection.
- Open Access
- 10 January 2023
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 23 (1) , 1-12
Mechanical ventilation and death in pregnant patients admitted for COVID-19: a prognostic analysis from the Brazilian COVID-19 registry score
Background: The assessment of clinical prognosis of pregnant COVID-19 patients at hospital presentation is challenging, due to physiological adaptations during pregnancy. Our aim was to assess the performance of the ABC2-SPH score to predict in-hospital mortality and mechanical ventilation support in pregnant patients with COVID-19, to assess the frequency of adverse pregnancy outcomes, and characteristics of pregnant women who died. Methods: This multicenter cohort included consecutive pregnant patients with COVID-19 admitted to the participating hospitals, from April/2020 to March/2022. Primary outcomes were in-hospital mortality and the composite outcome of mechanical ventilation support and in-hospital mortality. Secondary endpoints were pregnancy outcomes. The overall discrimination of the model was presented as the area under the receiver operating characteristic curve (AUROC). Overall performance was assessed using the Brier score. Results: From 350 pregnant patients (median age 30 [interquartile range (25.2, 35.0)] years-old]), 11.1% had hypertensive disorders, 19.7% required mechanical ventilation support and 6.0% died. The AUROC for in-hospital mortality and for the composite outcome were 0.809 (95% IC: 0.641–0.944) and 0.704 (95% IC: 0.617–0.792), respectively, with good overall performance (Brier = 0.0384 and 0.1610, respectively). Calibration was good for the prediction of in-hospital mortality, but poor for the composite outcome. Women who died had a median age 4 years-old higher, higher frequency of hypertensive disorders (38.1% vs. 9.4%, p < 0.001) and obesity (28.6% vs. 10.6%, p = 0.025) than those who were discharged alive, and their newborns had lower birth weight (2000 vs. 2813, p = 0.001) and five-minute Apgar score (3.0 vs. 8.0, p < 0.001). Conclusions: The ABC2-SPH score had good overall performance for in-hospital mortality and the composite outcome mechanical ventilation and in-hospital mortality. Calibration was good for the prediction of in-hospital mortality, but it was poor for the composite outcome. Therefore, the score may be useful to predict in-hospital mortality in pregnant patients with COVID-19, in addition to clinical judgment. Newborns from women who died had lower birth weight and Apgar score than those who were discharged alive.
- 10 January 2023
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 23 (1) , 1-12
Open AccessMechanical ventilation and death in pregnant patients admitted for COVID-19: a prognostic analysis from the Brazilian COVID-19 registry score
Background: The assessment of clinical prognosis of pregnant COVID-19 patients at hospital presentation is challenging, due to physiological adaptations during pregnancy. Our aim was to assess the performance of the ABC2-SPH score to predict in-hospital mortality and mechanical ventilation support in pregnant patients with COVID-19, to assess the frequency of adverse pregnancy outcomes, and characteristics of pregnant women who died. Methods: This multicenter cohort included consecutive pregnant patients with COVID-19 admitted to the participating hospitals, from April/2020 to March/2022. Primary outcomes were in-hospital mortality and the composite outcome of mechanical ventilation support and in-hospital mortality. Secondary endpoints were pregnancy outcomes. The overall discrimination of the model was presented as the area under the receiver operating characteristic curve (AUROC). Overall performance was assessed using the Brier score. Results: From 350 pregnant patients (median age 30 [interquartile range (25.2, 35.0)] years-old]), 11.1% had hypertensive disorders, 19.7% required mechanical ventilation support and 6.0% died. The AUROC for in-hospital mortality and for the composite outcome were 0.809 (95% IC: 0.641–0.944) and 0.704 (95% IC: 0.617–0.792), respectively, with good overall performance (Brier = 0.0384 and 0.1610, respectively). Calibration was good for the prediction of in-hospital mortality, but poor for the composite outcome. Women who died had a median age 4 years-old higher, higher frequency of hypertensive disorders (38.1% vs. 9.4%, p < 0.001) and obesity (28.6% vs. 10.6%, p = 0.025) than those who were discharged alive, and their newborns had lower birth weight (2000 vs. 2813, p = 0.001) and five-minute Apgar score (3.0 vs. 8.0, p < 0.001). Conclusions: The ABC2-SPH score had good overall performance for in-hospital mortality and the composite outcome mechanical ventilation and in-hospital mortality. Calibration was good for the prediction of in-hospital mortality, but it was poor for the composite outcome. Therefore, the score may be useful to predict in-hospital mortality in pregnant patients with COVID-19, in addition to clinical judgment. Newborns from women who died had lower birth weight and Apgar score than those who were discharged alive.
- 1 May 2021
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 20 (3) , 473-484
Extensive CFTR sequencing through NGS in Brazilian individuals with cystic fibrosis: unravelling regional discrepancies in the country
- 1 May 2021
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 20 (3) , 473-484
Extensive CFTR sequencing through NGS in Brazilian individuals with cystic fibrosis: unravelling regional discrepancies in the country